Ruminococcus bicirculans

Information

Microbe Identification

Ruminococcus bicirculans

Microbe id: PMDBM2021394
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Ruminococcus bicirculans [1160721]
Taxonomy Genus: Ruminococcus [1263]
Taxonomy Family: Oscillospiraceae [216572]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Ruminococcus bicirculans

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
Unclassified gene clustern.a.Others HGD unassignedPMID: 36782070
Unclassified gene clusterAromatic amino acids / proline / glutamate / leucine / histidine / arginineOD AA metabolismPMID: 29168502 / PMID: 20937090 / PMID: 27994578 / PMID: 15654892 / PMID: 22933560 / PMID: 30183487
Rnf complex C. sporogenesEnergy-capturing-relatedRnf complexPMID: 23269825
Arginine2putrescine R. gnavusPutrescine / argininePutrescine to spermidine,Arginine to putrescinePMID: 30183487 / PMID: 30183487
Pyruvate to acetate-formate E. coliPyruvatePyruvate to acetate-formatePMID: 20622067

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Ruminococcus bicirculans


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Unclassified gene clustern.a.Cyclic-lactone-autoinducerPMID: 34019648
Unclassified gene clustern.a.Cyclic-lactone-autoinducerPMID: 34019648
Unclassified gene clustern.a.RanthipeptidePMID: 34019648
Unclassified gene clustern.a.Cyclic-lactone-autoinducerPMID: 34019648
Unclassified gene clustern.a.Cyclic-lactone-autoinducerPMID: 34019648

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Ruminococcus bicirculans distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Ruminococcus bicirculans in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Ruminococcus bicirculans

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗-3.88305905205648mNGS
Hypertension PRJNA509999🔗3.66026691020993mNGS
Hypertension PRJNA509999🔗3.71981542825573mNGS
Arthritis, Juvenile PRJNA562467🔗-3.9129137511174816S
Diabetes Mellitus, Type 2 PRJDB5860🔗-4.3152812337315416S
Diabetes Mellitus, Type 2 PRJNA399794🔗-4.0912273427069916S
Liver Cirrhosis, Alcoholic PRJNA690835🔗-4.715190681084716S
Diarrhea PRJEB14038🔗-4.24464191055929mNGS
Diarrhea PRJNA317326🔗-4.0466492571848116S
Diarrhea PRJEB14038🔗-3.77879993350768mNGS
Colorectal Neoplasms PRJEB70916🔗-4.69170201995333mNGS
Colorectal Neoplasms PRJNA936589🔗-4.59214537570973mNGS
Colorectal Neoplasms PRJNA961076🔗-4.43055960321053mNGS
Colorectal Neoplasms PRJEB70916🔗-4.36609514250548mNGS
Colorectal Neoplasms PRJNA284542🔗-4.1742120519193616S
Colorectal Neoplasms PRJNA731589🔗-4.12625950341712mNGS
Colorectal Neoplasms PRJNA1138893🔗-4.12222167315646mNGS
Colorectal Neoplasms PRJEB46665🔗-4.0156191251373116S
Colorectal Neoplasms PRJNA698923🔗-3.9820619868224316S
Colorectal Neoplasms PRJNA763023🔗-3.90579369177748mNGS
Colorectal Neoplasms PRJEB53891🔗-3.82759401389358mNGS
Colorectal Neoplasms PRJNA1167935🔗-3.67194996264181mNGS
Colorectal Neoplasms PRJNA936589🔗3.49695062896777mNGS
Colorectal Neoplasms PRJEB53415🔗3.5418164909184316S
Lupus Erythematosus, Systemic PRJEB39044🔗-4.4545589030997316S
Lupus Erythematosus, Systemic PRJEB52971🔗-4.1129214918129216S
Tuberculosis PRJNA795263🔗-4.2011708337527616S
Parkinson Disease PRJNA742875🔗-4.1964727061982616S
Colitis, Ulcerative PRJEB6172🔗-4.4567328384353616S
Colitis, Ulcerative PRJNA398089🔗-4.20441889464386mNGS
Colitis, Ulcerative PRJNA993675🔗-3.92714658656073mNGS
Colitis, Ulcerative PRJNA804422🔗-3.7221640079214816S
Colitis, Ulcerative PRJNA820056🔗-3.7125299735483616S
Colitis, Ulcerative PRJNA993675🔗-3.56069994934593mNGS
Colitis, Ulcerative PRJNA398089🔗-3.45854819559561mNGS
Colitis, Ulcerative PRJNA429990🔗3.32382473231156mNGS
Campylobacter Infections PRJNA660443🔗-4.2496473558288mNGS
Campylobacter Infections PRJNA660443🔗-3.81729850933278mNGS
Spinal Cord Injuries PRJNA861246🔗-4.0725036730876416S
Spinal Cord Injuries PRJNA669472🔗-3.7428354650840516S
Hepatitis B, Chronic PRJNA872871🔗3.8835246067494516S
Carcinoma, Hepatocellular PRJNA932948🔗-4.25450849210756mNGS
Celiac Disease PRJNA890948🔗-4.3648360122266816S
Celiac Disease PRJNA385740🔗-4.1349431210228116S
Spondylarthritis PRJNA342486🔗-4.32694668018416S
Caliciviridae Infections PRJNA788674🔗-3.8951487986190716S
Hepatolenticular Degeneration PRJNA1038771🔗-3.8777915564013516S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.3357175723997916S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗-4.295901154782716S
Hidradenitis Suppurativa PRJEB43835🔗-4.2006527250421916S
Asthma PRJEB59709🔗4.09235646369768mNGS
Asthma PRJEB59709🔗4.51172445828586mNGS
Leukemia, Myeloid, Acute PRJNA813705🔗-4.08757485362493mNGS
Crohn Disease PRJEB42155🔗-4.40535938269621mNGS
Crohn Disease PRJNA938107🔗-4.276993798881216S
Crohn Disease PRJNA993675🔗-4.25245710996246mNGS
Crohn Disease PRJNA813736🔗-4.23690991573475mNGS
Crohn Disease PRJNA793776🔗-4.22330594181314mNGS
Crohn Disease PRJNA398089🔗-4.0221904235004mNGS
Crohn Disease PRJNA793776🔗-3.93817285364435mNGS
Crohn Disease PRJNA820056🔗-3.8297132703273216S
Crohn Disease PRJNA917086🔗-3.7661521695371216S
Crohn Disease PRJEB42155🔗-3.75404698837719mNGS
Crohn Disease PRJNA993675🔗-3.67837193239612mNGS
Crohn Disease PRJNA429990🔗-3.65184317844524mNGS
Crohn Disease PRJNA813736🔗-3.64161626372628mNGS
Crohn Disease PRJNA398089🔗-3.35079062241924mNGS
Cholestasis PRJNA478781🔗-3.0828950217474216S
Multiple System Atrophy PRJNA532538🔗3.66480793123032mNGS
Dermatitis, Atopic PRJEB45443🔗-3.71264347037831mNGS
Arthritis, Rheumatoid PRJNA786110🔗-4.0280476281481616S
Arthritis, Rheumatoid PRJNA896336🔗4.13758714861869mNGS
Arthritis, Rheumatoid PRJNA896336🔗4.59429531316468mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗-3.73107475239047mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗-3.50859060798656mNGS
Anorexia PRJNA674716🔗-4.53453657881728mNGS
Anorexia PRJNA674716🔗-4.40110644281052mNGS
Autoimmune Diseases of the Nervous System PRJNA586763🔗4.3936086294077916S
Cholangiocarcinoma PRJNA932948🔗-4.17671840470945mNGS
Growth Hormone-Secreting Pituitary Adenoma PRJNA743650🔗3.0863911015491816S
Anorexia Nervosa PRJEB38930🔗-3.5812936223371516S
Hepatitis C PRJNA1070593🔗-3.660360207927416S
Hepatitis C PRJNA328966🔗-3.5579036483455216S
Neuroblastoma PRJEB63351🔗-4.21843535519652mNGS
Neuroblastoma PRJEB63351🔗-3.78230865943849mNGS
Hematologic Neoplasms PRJNA777832🔗-4.3291666956469116S
Myasthenia Gravis PRJNA688881🔗-4.07112652498109mNGS
Irritable Bowel Syndrome PRJEB37924🔗-4.3074866712335mNGS
Irritable Bowel Syndrome PRJNA637763🔗-4.1729573777904216S
Irritable Bowel Syndrome PRJNA682378🔗4.1388064205830316S
IgA Deficiency PRJNA967340🔗4.0656639654127516S
Depressive Disorder, Major PRJNA591924🔗-4.0101458437533116S
Epilepsy PRJNA506309🔗-4.2256823405338116S
Clostridium Infections PRJNA648321🔗-4.00660127547959mNGS
Kidney Calculi PRJNA742740🔗-4.44534462026944mNGS
Kidney Calculi PRJNA742740🔗-4.0656279218683mNGS
Cholelithiasis PRJNA999028🔗-4.40251743326682mNGS
Alzheimer Disease PRJEB51982🔗-4.5545313097964916S
Lung Neoplasms PRJNA736821🔗-3.9378526723382716S
Glomerulonephritis, IGA PRJNA785415🔗-3.9337360894583816S
Liver Cirrhosis PRJNA861246🔗-4.1008063748511316S
Cystic Fibrosis PRJNA314903🔗-4.59205069597988mNGS
Cystic Fibrosis PRJNA314903🔗-4.03139995213084mNGS
Anti-N-Methyl-D-Aspartate Receptor Encephalitis PRJNA764676🔗-3.9535898756548616S
Diabetes Mellitus PRJNA400325🔗-4.2588025811076616S
HIV Infections PRJNA810567🔗-4.3998343151736916S
HIV Infections PRJDB11949🔗-3.5954697524117916S
HIV Infections PRJNA408085🔗3.5107666167734116S
Autism Spectrum Disorder PRJNA917543🔗-3.9781788438941416S
Inflammatory Bowel Diseases PRJNA1028828🔗-4.0632653933021416S
Rhinitis, Allergic PRJNA692671🔗-4.0001874600645916S
Biliary Atresia PRJNA730640🔗-3.90182467930124mNGS
Renal Insufficiency, Chronic PRJNA659589🔗-3.5779449912247416S
Multiple Sclerosis PRJEB34168🔗-4.1347512481108516S
Fibromyalgia PRJEB80379🔗-4.44791985589289mNGS
Fibromyalgia PRJEB80379🔗-3.78405672884902mNGS
Breast Neoplasms PRJNA658160🔗3.1136321406023216S
COVID-19 PRJNA689961🔗-4.54739217784384mNGS
COVID-19 PRJNA624223🔗-4.41689736846466mNGS
COVID-19 PRJNA769052🔗4.1545050377525216S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Ruminococcus bicirculans



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Ruminococcus bicirculans



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Ruminococcus bicirculans

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Ruminococcus bicirculans


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Ruminococcus bicirculans



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Ruminococcus bicirculans

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Ruminococcus bicirculans

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Ruminococcus bicirculans

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Ruminococcus bicirculans



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Ruminococcus bicirculans


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Ruminococcus bicirculans


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?